Multimodality standard of care treatment of resectable and borderline resectable pancreatic cancer
Hepatobiliary Surg Nutr
.
2021 Oct;10(5):714-716.
doi: 10.21037/hbsn-21-131.
Authors
John P Neoptolemos
1
,
Paula Ghaneh
2
,
Thilo Hackert
1
Affiliations
1
Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany.
2
Department of Clinical Cancer Medicine, Institute of Systems, Molecular and Integrative Biology, The University of Liverpool, Liverpool, UK.
PMID:
34760983
PMCID:
PMC8527429
DOI:
10.21037/hbsn-21-131
No abstract available
Publication types
Editorial
Comment
Grants and funding
16186/CRUK_/Cancer Research UK/United Kingdom
17680/CRUK_/Cancer Research UK/United Kingdom
8968/CRUK_/Cancer Research UK/United Kingdom
15957/CRUK_/Cancer Research UK/United Kingdom
16812/CRUK_/Cancer Research UK/United Kingdom
11883/CRUK_/Cancer Research UK/United Kingdom